Food and Drug Administration

Center for Drug Evaluation and Research

Endocrinologic and Metabolic Drugs Advisory Committee

Holiday Inn Bethesda

8120 Wisconsin Avenue, Bethesda, MD

July 27, 2001

NDA 21-318, FortéoTM (teriparatide injection, rDNA origin) Eli Lilly and Company

Special Government Employee Consultants

Acting Chair:

Mark E. Molitch, M.D.

Professor of Medicine

Northwestern University Medical School

Center for Endocrinology, Metabolism and Molecular Medicine

303 East Chicago Avenue

Tarry Building., Room 15-731

Chicago, Illinois 60611


Robert A. Kreisberg, M.D.

Dean, School of Medicine

University of South Alabama

307 University Boulevard, Rm. 170 CSAB

Mobile, Alabama 36688


Risk Management Consultant:

Eric S. Holmboe, M.D., FACP

Yale University School of Medicine

1074 LMP

333 Center Street

New Haven, CT 06510


Consumer Representative:

Jody L. Pelosi, F.N.P., Ph.D.

Phoenix Indian Medical Center

4212 North 16th Street

Phoenix, AZ 85016



Henry G. Bone III, M.D.

Director, Michigan Bone and Mineral Clinic

22201 Moross Road, Suite 260

Detroit, Michigan 48236